Abstract
Thyroid hormones are key regulators of development, growth, and metabolism. Growth and function of thyroid cells are controlled by positive and negative feedback mediated by the hypothalamic-pituitary-thyroid axis. Appropriate thyroid hormone synthesis requires a normally developed thyroid gland, an intact hypothalamic-pituitary-thyroid axis, adequate iodine intake, and a series of regulated biochemical reactions within thyroid follicular cells. Circulating thyroid hormones are primarily bound to plasma proteins, and only a small portion is present as free hormone. Thyroid hormones enter the cell nucleus and act predominantly by altering genomic activity via nuclear receptors, but they can also exert non-genomic activity through interactions with mitochondrial and plasma membrane proteins.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aoki Y, Belin RM, Clickner R, Jeffries R, Phillips L, Mahaffey KR. Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999-2002). Thyroid. 2007;17(12):1211–23.
Alexander EK, Pearce EN, Brent GA, Brown RS, Chen H, Dosiou C, et al. 2017 guidelines of the American Thyroid Association for the diagnosis and Management of Thyroid Disease during pregnancy and the postpartum. Thyroid. 2017;27(3):315–89.
Maraka S, Singh Ospina NM, O'Keeffe DT, Rodriguez-Gutierrez R, Espinosa De Ycaza AE, Wi CI, et al. Effects of levothyroxine therapy on pregnancy outcomes in women with subclinical hypothyroidism. Thyroid. 2016;26(7):980–6.
Cooper DS, Pearce EN. Subclinical hypothyroidism and hypothyroxinemia in pregnancy – still no answers. N Engl J Med. 2017;376(9):876–7.
Skudlinski M, Kazlauskaite R, Weintraub B. Thyroid-stimulating hormone and regulation of the thyroid axis. In: DeGroot LJ, Jameson JL, editors. Endocrinology. 2Vols. 5th ed. Philadelphia: Elsevier; 2006, p. 1803–22.
Kopp P. The TSH receptor and its role in thyroid disease. Cell Mol Life Sci. 2001;58(9):1301–22.
Benvenga S. Thyroid hormone transport proteins and the physiology of hormone binding. In: Braverman L, Utiger R, editors. Werner and Ingbar's the thyroid: a fundamental and clinical text. 9th ed. Philadelphia: Lippincott, Williams & Wilkins; 2005. p. 97–108.
Bernal J, Guadano-Ferraz A, Morte B. Thyroid hormone transporters--functions and clinical implications. Nat Rev Endocrinol. 2015;11(7):406–17.
Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev. 2002;23(1):38–89.
Ortiga-Carvalho TM, Sidhaye AR, Wondisford FE. Thyroid hormone receptors and resistance to thyroid hormone disorders. Nat Rev Endocrinol. 2014;10(10):582–91.
Kopp P. Thyroid hormone synthesis: thyroid iodine metabolism. In: Braverman L, Utiger R, editors. Werner and Ingbar's the thyroid: a fundamental and clinical text. 10th ed. Philadelphia: Lippincott, Williams & Wilkins; 2013. p. 48–74.
Dohan O, De la Vieja A, Paroder V, Riedel C, Artani M, Reed M, et al. The sodium/iodide symporter (NIS): characterization, regulation, and medical significance. Endocr Rev. 2003;24(1):48–77.
Ravera S, Reyna-Neyra A, Ferrandino G, Amzel LM, Carrasco N. The sodium/iodide symporter (NIS): molecular physiology and preclinical and clinical applications. Annu Rev Physiol. 2017;79:261–89.
Wemeau JL, Kopp P. Pendred syndrome. Best Pract Res Clin Endocrinol Metab. 2017;31(2):213–24.
Taurog A. Hormone synthesis: thyroid iodine metabolism. In: Braverman L, Utiger R, editors. Werner and Ingbar's the thyroid: a fundamental and clinical text. 8th ed. Philadelphia: Lippincott, Williams & Wilkins; 2000. p. 61–85.
Moreno JC, Visser TJ. New phenotypes in thyroid dyshormonogenesis: hypothyroidism due to DUOX2 mutations. Endocr Dev. 2007;10:99–117.
Visser WE, Friesema EC, Visser TJ. Minireview: thyroid hormone transporters: the knowns and the unknowns. Mol Endocrinol (Baltimore, Md). 2011;25(1):1–14.
Di Jeso B, Arvan P. Thyroglobulin from molecular and cellular biology to clinical endocrinology. Endocr Rev. 2016;37(1):2–36.
Moreno JC, Klootwijk W, van Toor H, Pinto G, D'Allessandro M, Leger A, et al. Mutations in the iodotyrosine deiodinase gene and hypothyroidism. N Engl J Med. 2008;358(17):1811–8.
Martin T, Findlay D, Sexton P. Calcitonin. In: DeGroot LJ, Jameson JL, editors. Endocrinology. 2 vols. 5th ed. Philadelphia: Elsevier; 2006, p. 1419–33.
Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C, et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab. 2001;86(12):5658–71.
Dohan O, Portulano C, Basquin C, Reyna-Neyra A, Amzel LM, Carrasco N. The Na+/I symporter (NIS) mediates electroneutral active transport of the environmental pollutant perchlorate. Proc Natl Acad Sci U S A. 2007;104(51):20250–5.
Hilditch TE, Horton PW, McCruden DC, Young RE, Alexander WD. Defects in intrathyroid binding of iodine and the perchlorate discharge test. Acta Endocrinol. 1982;100(2):237–44.
Tazebay UH, Wapnir IL, Levy O, Dohan O, Zuckier LS, Zhao QH, et al. The mammary gland iodide transporter is expressed during lactation and in breast cancer. Nat Med. 2000;6(8):871–8.
Grollman EF, Smolar A, Ommaya A, Tombaccini D, Santisteban P. Iodine suppression of iodide uptake in FRTL-5 thyroid cells. Endocrinology. 1986;118(6):2477–82.
Kogai T, Curcio F, Hyman S, Cornford EM, Brent GA, Hershman JM. Induction of follicle formation in long-term cultured normal human thyroid cells treated with thyrotropin stimulates iodide uptake but not sodium/iodide symporter messenger RNA and protein expression. J Endocrinol. 2000;167(1):125–35.
Eng PH, Cardona GR, Previti MC, Chin WW, Braverman LE. Regulation of the sodium iodide symporter by iodide in FRTL-5 cells. Eur J Endocrinol. 2001;144(2):139–44.
Wolff J, Chaikoff I. Plasma inorganic iodide as homeostatic regulator of thyroid function. J Biol Chem. 1948;174:555–64.
Wolff J, Chaikoff I, Goldberg R, Meier J. The temporary nature of the inhibitory action of excess iodide on organic iodide synthesis in the normal thyroid. Endocrinology. 1949;45:504–13.
Braverman LE, Ingbar SH. Changes in thyroidal function during adaptation to large doses of iodide. J Clin Invest. 1963;42:1216–31.
Gillam MP, Sidhaye A, Lee EJ, Rutishauser J, Waeber Stephan C, Kopp P. Functional characterization of pendrin in a polarized cell system: evidence for pendrin-mediated apical iodide efflux. J Biol Chem. 2004;279:13004–10.
Everett LA, Glaser B, Beck JC, Idol JR, Buchs A, Heyman M, et al. Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS). Nat Genet. 1997;17:411–22.
Pesce L, Bizhanova A, Caraballo JC, Westphal W, Butti ML, Comellas A, et al. TSH regulates pendrin membrane abundance and enhances iodide efflux in thyroid cells. Endocrinology. 2012;153(1):512–21.
Iosco C, Cosentino C, Sirna L, Romano R, Cursano S, Mongia A, et al. Anoctamin 1 is apically expressed on thyroid follicular cells and contributes to ATP- and calcium-activated iodide efflux. Cell Physiol Biochem. 2014;34(3):966–80.
Twyffels L, Strickaert A, Virreira M, Massart C, Van Sande J, Wauquier C, et al. Anoctamin-1/TMEM16A is the major apical iodide channel of the thyrocyte. Am J Physiol Cell Physiol. 2014;307(12):C1102–12.
Vono-Toniolo J, Rivolta CM, Targovnik HM, Medeiros-Neto G, Kopp P. Naturally occurring mutations in the thyroglobulin gene. Thyroid. 2005;15(9):1021–33.
Haugen B, Alexander E, Bible K, Doherty G, Mandel S, Nikiforov Y, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26:1–133.
Bakker B, Bikker H, Vulsma T, de Randamie JS, Wiedijk BM, De Vijlder JJ. Two decades of screening for congenital hypothyroidism in the Netherlands: TPO gene mutations in total iodide organification defects (an update). J Clin Endocrinol Metab. 2000;85:3708–12.
Grasberger H, Refetoff S. Genetic causes of congenital hypothyroidism due to dyshormonogenesis. Curr Opin Pediatr. 2011;23(4):421–8.
Di Cosmo C, Liao XH, Dumitrescu AM, Philp NJ, Weiss RE, Refetoff S. Mice deficient in MCT8 reveal a mechanism regulating thyroid hormone secretion. J Clin Invest. 2010;120(9):3377–88.
Friesema EC, Grueters A, Biebermann H, Krude H, von Moers A, Reeser M, et al. Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation. Lancet (London, England). 2004;364(9443):1435–7.
Dumitrescu AM, Liao XH, Best TB, Brockmann K, Refetoff S. A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene. Am J Hum Genet. 2004;74(1):168–75.
Bartalena L, Robbins J. Variations in thyroid hormone transport proteins and their clinical implications. Thyroid. 1992;2(3):237–45.
Kopp P. Genetic basis of thyroid disorders. In: Ganten D, Ruekpaul K, editors. Genomics and proteomics in molecular medicine. 2nd ed. Berlin: Springer; 2006. p. 1862–7.
Glinoer D, de Nayer P, Bourdoux P, Lemone M, Robyn C, van Steirteghem A, et al. Regulation of maternal thyroid during pregnancy. J Clin Endocrinol Metab. 1990;71(2):276–87.
Cooper DS, Ladenson PW. The thyroid gland. In: Gardner DG, Shoback D, editors. Greenspan’s basic & clinical endocrinology, 10e. New York: McGraw-Hill Education; 2017.
Refetoff S. Thyroid Hormone Serum Transport Proteins. June 7, 2015. In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, et al., editors. Endotext. South Dartmouth; 2000.
Pappa T, Ferrara AM, Refetoff S. Inherited defects of thyroxine-binding proteins. Best Pract Res Clin Endocrinol Metab. 2015;29(5):735–47.
Bianco AC. Minireview: cracking the metabolic code for thyroid hormone signaling. Endocrinology. 2011;152(9):3306–11.
Williams GR, Bassett JH. Deiodinases: the balance of thyroid hormone: local control of thyroid hormone action: role of type 2 deiodinase. J Endocrinol. 2011;209(3):261–72.
Van den Berghe G. Non-thyroidal illness in the ICU: a syndrome with different faces. Thyroid. 2014;24(10):1456–65.
Cheng SY, Leonard JL, Davis PJ. Molecular aspects of thyroid hormone actions. Endocr Rev. 2010;31(2):139–70.
Astapova I, Hollenberg AN. The in vivo role of nuclear receptor corepressors in thyroid hormone action. Biochim Biophys Acta. 2013;1830(7):3876–81.
Ortiga-Carvalho TM, Shibusawa N, Nikrodhanond A, Oliveira KJ, Machado DS, Liao XH, et al. Negative regulation by thyroid hormone receptor requires an intact coactivator-binding surface. J Clin Invest. 2005;115(9):2517–23.
Refetoff S. Inherited thyroxine-binding globulin abnormalities in man. Endocr Rev. 1989;10:275–93.
Refetoff S, Bassett JH, Beck-Peccoz P, Bernal J, Brent G, Chatterjee K, et al. Classification and proposed nomenclature for inherited defects of thyroid hormone action, cell transport, and metabolism. Thyroid. 2014;24(3):407–9.
Refetoff S, Dumitrescu AM. Syndromes of reduced sensitivity to thyroid hormone: genetic defects in hormone receptors, cell transporters and deiodination. Best Pract Res Clin Endocrinol Metab. 2007;21(2):277–305.
Bochukova E, Schoenmakers N, Agostini M, Schoenmakers E, Rajanayagam O, Keogh JM, et al. A mutation in the thyroid hormone receptor alpha gene. N Engl J Med. 2012;366(3):243–9.
Moran C, Agostini M, McGowan A, Schoenmakers E, Fairall L, Lyons G, et al. Contrasting phenotypes in resistance to thyroid hormone alpha correlate with divergent properties of thyroid hormone receptor alpha1 mutant proteins. Thyroid. 2017;27(7):973–82.
van Gucht AL, Meima ME, Zwaveling-Soonawala N, Visser WE, Fliers E, Wennink JM, et al. Resistance to thyroid hormone alpha in an 18-month-old girl: clinical, therapeutic, and molecular characteristics. Thyroid. 2016;26(3):338–46.
Davis PJ, Goglia F, Leonard JL. Nongenomic actions of thyroid hormone. Nat Rev Endocrinol. 2016;12(2):111–21.
Krassas GE, Poppe K, Glinoer D. Thyroid function and human reproductive health. Endocr Rev. 2010;31(5):702–55.
Refetoff S, Weiss RE, Usala SJ. The syndromes of resistance to thyroid hormone. Endocr Rev. 1993;14(3):348–99.
Acknowledgment
Malini Soundarrajan is supported by a Ruth L. Kirschstein National Research Service Award T32 DK007169 from NIH/NIDDK.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Soundarrajan, M., Kopp, P.A. (2019). Thyroid Hormone Biosynthesis and Physiology. In: Eaton, J. (eds) Thyroid Disease and Reproduction. Springer, Cham. https://doi.org/10.1007/978-3-319-99079-8_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-99079-8_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-99078-1
Online ISBN: 978-3-319-99079-8
eBook Packages: MedicineMedicine (R0)